Sanofi (ADR) (NYSE:SNY)

passenger cabin

Major Changes in Warren Buffett & Berkshire Hathaway Stocks: American Airlines, Delta, Kinder Morgan, Wal-Mart, BNY Mellon and More

Berkshire Hathaway Inc. (NYSE: BRK-A) has released its public equity holdings as of September 30, 2016. Outside of Warren Buffett being one of the richest men alive and being considered the ...
Read Full Story »
thumbs up and down

Top Analyst Upgrades and Downgrades: Apple, Callon Petroleum, Hewlett Packard Enterprise, Lululemon, Nike, Rio Tinto and More

Stocks were looking for direction on Thursday, and we are now over 50 days without a 1% move in either direction, despite being close to all-time highs. One thing that ...
Read Full Story »
analysis

Sanofi Just Can’t Catch a Break, Knocking at Major Support Again

Investor sentiment surrounding French pharma giant Sanofi S.A. (NYSE: SNY) continues to sour after a string of disappointing news in recent months has brought its shares down below the key ...
Read Full Story »
Prescription drugs

Pfizer Pays a Big Premium for Medivation

In one of the longest running bidding wars in recent times, Pfizer Inc. (NYSE: PFE) has finally reeled in cancer-drug maker Medivation Inc. (NASDAQ: MDVN) for a whopping $81.50 a ...
Read Full Story »
money

How Much Medivation Can Really Fetch in a Buyout

Medivation Inc. (NASDAQ: MDVN) has been among the top future biotech mergers for quite some time. The problem is that we still have no idea which company will buy Medivation, ...
Read Full Story »
Warren Buffett square

Major Changes Seen in Warren Buffett and Berkshire Hathaway Stocks: Apple, Wal-Mart, Phillips 66, Deere and More

Berkshire Hathaway Inc. (NYSE: BRK-A) has released its public equity holdings as of June 30, 2016. What makes this so interesting for Warren Buffett fans, outside of Buffett being one ...
Read Full Story »
bigger fish

How Medivation Shareholders May Lose Big by Poison Pill in Hostile Takeover Fight With Sanofi

Sanofi S.A. (NYSE: SNY) wants Medivation Inc. (NASDAQ: MDVN) and it is going to extreme lengths to get it. Usually the term “hostile takeover” is an exaggeration, but in this case ...
Read Full Story »
mosquito

7 Companies in the Fight to Defeat the Zika Virus

In 2016, it is the Zika virus that has the public worried about the next pandemic. Past scares have been around Ebola, E. coli, SARS, mad cow, swine flu and ...
Read Full Story »
Warren Buffett

Major Changes Seen in Warren Buffett and Berkshire Hathaway Stock Holdings — Including Apple

Being the wealthiest man in the world on paper tends to draw some attention. This is why investors and outsiders watch new equity investment positions taken by, or sold by, ...
Read Full Story »
Prescription drugs

Analysts Adjust Predictions on Medivation Buyout Price

One time when missing earnings estimates doesn't matter much is when there is bidding war for the company. That's the position that Medivation Inc. (NASDAQ: MDVN) found itself in after ...
Read Full Story »
Warren Buffet

Major Changes Seen in Warren Buffett and Berkshire Hathaway Stocks for 2016

Warren Buffett has now released the official equity holdings of Berkshire Hathaway Inc. (NYSE: BRK-A) as of December 31, 2016. That makes this the official Buffett stocks for 2016, but ...
Read Full Story »
investing

Major Changes Seen in Warren Buffett and Berkshire Hathaway Stock Holdings

Warren Buffett and Berkshire Hathaway Inc. (NYSE: BRK-A) have released their official equity holdings of Berkshire Hathaway as of September 30, 2015. 24/7 Wall St. has followed this trend for ...
Read Full Story »
Automatic Inspection Machine - Ampules

Why RBC Is Now So Negative Against MannKind

MannKind Corp. (NASDAQ: MNKD) remains one of the most controversial bio-health stocks of them all. Its stock was under pressure on Wednesday on news of a key analyst downgrade. The ...
Read Full Story »
Buffet

Key Changes in Warren Buffett and Berkshire Hathaway Stock Holdings

Warren Buffett and Berkshire Hathaway Inc. (NYSE: BRK-A) have released the official equity holdings of Berkshire Hathaway as of June 30, 2015. It has been the case for years now ...
Read Full Story »
Biotechnology word cloud

Have Analysts Fully Priced in Praluent to Regeneron?

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NYSE: SNY) announced last Friday that the U.S. Food and Drug Administration (FDA) approved Praluent (alirocumab) Injection. Praluent is indicated as an adjunct ...
Read Full Story »